HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: trastuzumab|DRUG: vinorelbine
Sponsor: National Cancer Institute, Naples